A new study published in The American Journal of Pathology provides new evidence that immune cells enter the retina via the body's standard pathway, identifying Platelet Endothelial Cell Adhesion Molecule (PECAM; also known as CD31) as the gatekeeper and neutrophils as proresolving mediators. This research offers new insights into how eye inflammation develops and could lead to better-targeted treatment options.
Retina Global is a US based 501(c)(3) nonprofit that is focused on finding sustainable solutions to the ever-increasing issues with retinal diseases in underserved areas around the world. We also manage the Orange County Eye Project in Santa Ana, CA.
Showing posts with label uveitis. Show all posts
Showing posts with label uveitis. Show all posts
Wednesday, September 16, 2026
Wednesday, September 23, 2020
COVID-19 and the Retina - how does this Coronavirus affect the back of the eye?
![]() |
| (c) Wikipedia |
As the coronavirus pandemic evolves and spreads worldwide, more information emerges on how the virus affects the body. What was once a respiratory illness has now become a systemic infection, affecting multiple organs.
Monday, March 5, 2018
Clearside's CLS-TA achieves endpoints in Phase 3 PEACHTREE trial
Labels:
Clearside,
Corticosteroid,
Macular Edema,
Suprachoroidal,
Triamcinolone,
uveitis
Subscribe to:
Posts (Atom)

